AI Insight
Growth hormone peptides like sermorelin and tesamorelin are being marketed as anti-aging treatments, but the scientific evidence supporting these claims remains limited. While these peptides can stimulate growth hormone release in the body, their purported benefits for reversing aging processes lack robust clinical validation. The article examines the gap between promotional claims and actual research findings regarding these compounds' efficacy and safety for anti-aging purposes.
Why it matters
The growing market for anti-aging peptides raises concerns about consumers making health decisions based on unsubstantiated claims rather than solid scientific evidence. Understanding the actual evidence base is important for both regulatory oversight and informed patient decision-making regarding these increasingly popular but potentially unproven treatments.
Understand the Science
Sermorelin, tesamorelin and other growth hormone peptides are being touted as antiaging elixirs, but what evidence is behind those claims?
Source: Growth hormone peptides promise to stall aging—but does the science stack up?